Utah Medical Products, Inc.
UTMD · Price history
Price at last available close
$73.06
−$1.43 (-1.92%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Utah Medical Products, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth.
How they make money
Utah Medical Products, Inc. develops, manufactures, and markets specialized medical devices primarily for women's health, labor and delivery, and neonatal intensive care. The company generates revenue through direct sales to clinical end-user facilities, sales to stocking distributors, and by providing contract manufacturing services for other medical device companies.
Products & services
Specialty medical devices including fetal monitoring accessories, vacuum-assisted delivery systems, neonatal respiratory hoods, blood pressure monitoring systems, gynecologic surgical tools, and female surgical contraception devices.
Brands & revenue mix
Female surgical contraception device.
Separate brand revenue is not available in this research.Source
Blood pressure monitoring system.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company does not disclose specific major customers or significant concentration levels in its 2025 annual report.
Suppliers, materials & equipment
- Raw material and component suppliers — The company relies on various suppliers for raw materials and components used in its plastics-forming, sensor production, and assembly operations.Source
Strengths
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
44
Weak
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
63
Fair
Financial Strength
89
Business Quality / Moat
22
Management
97
Growth Quality
9
Risk / Durability
96
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
24
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
28/100
Building Historical Record
Model Score 28/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •M&A headline · Aug 31, 2026
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for UTMD
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving UTMD's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is UTMD's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •How is UTMD likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What future growth or profitability would be needed to justify UTMD's current valuation?
Essential Investment Snapshot
Wall Street Score
44
Opportunity Score
24
Market Cap
$231.9M
P/E Ratio
22.3
EPS
$3.34
52-Week High
$76.89
52-Week Low
$53.66
Beta
0.39
Intrinsic Value
$28.41
Shares Outstanding
3.2M
Total Revenue
$34.9M
Total Debt
$180K
Dividend Yield (TTM)
1.70%
Liquidation Value / Share
$38.05
Dividend / Share (TTM)
$1.24
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for UTMD
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
M&A headline · Aug 31, 2026
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
AccesswireCommunity Sentiment
0 active · 0 total callsNo personal call yet on UTMD.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Vertically integrated manufacturing capabilities in Utah, Ireland, and the UK.
- +Diversified global distribution network.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Instruments & Supplies industry.
- −Dependence on successful product development and regulatory approvals.
- −Risks associated with international operations and foreign currency fluctuations.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
44
Oct 23, 2026
Change
-0.1
points
Current Score
44
Oct 26, 2026
Category Changes
UTMD decreased 0.1 points because some fundamentals weakened.
Projected Score
Projected Score
44
Projected Change
-0.1 points
Preliminary comparable-period financial changes suggest decline of approximately 0.1 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$73.06
Model Intrinsic Value
$28.41
Difference
+$44.65
+157.2% vs IV
Margin of Safety
-157.2%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.9M | $38.5M | $40.9M | $50.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $14.8M | $16.5M | $16.8M | $20.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $20.1M | $22.0M | $24.1M | $30.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $662K | $668K | $813K | $560K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $9.0M | $9.9M | $5.6M | $12.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $9.7M | $10.6M | $10.5M | $13.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $14.9M | $17.1M | $19.6M | $24.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $10.4M | $11.4M | $13.6M | $16.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $13.0M | $14.1M | $16.8M | $20.1M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $2.3M | $2.8M | $2.9M | $3.5M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $10.6M | $11.3M | $13.9M | $16.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $3.34 | $3.48 | $3.96 | $4.57 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 3.18M | 3.24M | 3.50M | 3.64M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 3.18M | 3.24M | 3.50M | 3.64M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$8.6M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.88
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-25.3%
Cash Change
+1.1%
Margin Change
+5.5 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
- Debt reduced
Potential Score Impact
Positive indicators included EPS growth, cash levels, debt levels, net income margin. Pressure indicators included revenue growth. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 12.1%. EPS increased 7.3%. Cash increased 1.1%. Total debt declined 25.3%. Net income margin improved by 5.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Log in to view dividend history.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Instruments & SuppliesNews
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Utah Medical Products, Inc. Extends Tender Offer
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
Rumor Mill · UTMD
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial